Evidence supports that lncR-Meg3 interacts with miRNA directly or competitively in tumors, metabolic diseases, immune system diseases, and cardio-cerebrovascular diseases, the mechanisms of which are tightly associated with apoptosis, proliferation, inflammation, and oxidative stress. Here, MEG3 is linked to metabolic disease.